Literature DB >> 23113534

Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system.

Graham Freimanis1, Mary Sedegah, Shirley Owusu-Ofori, Sanjai Kumar, Jean-Pierre Allain.   

Abstract

BACKGROUND: Prevention of transfusion-transmitted malaria in at-risk children and pregnant women in endemic areas with inexpensive chloroquine is no longer effective due to widespread drug resistance. There is an urgent need for devising new strategies for transfusion malarial safety. We investigated the frequency of transfusion transmission of malaria within the Ghanaian blood donation system using blood donations from 106 asymptomatic adult Ghanaian blood donors. STUDY DESIGN AND METHODS: Paired samples from 106 blood donations and recipients (before and after transfusion) were tested for anti-merozoite surface protein-1/2 using the commercial Lab21 malaria enzyme immunoassay (EIA), four antigen-specific in-house EIAs, and Plasmodium lactate dehydrogenase (pLDH) EIA. Additionally, Plasmodium DNA was screened for using a species-specific nested polymerase chain reaction (PCR) and a Pan-Plasmodium quantitative PCR. Donor-recipient parasite identity was defined by two concordant genotyping strategies.
RESULTS: Plasmodium antibody prevalence was 100% in both donors and recipients, with at least one antigen. Parasitemia prevalence was 54.7% in both donors and recipients with median levels of 20 and 5.3 copies/μL, respectively, the difference being correlated to age (p = 0.0001). Multiple species infections were frequent (8.5%). Twenty-four units of parasitemic blood were transfused to nonparasitemic recipients, of which 10 (41.7%) became infected after transfusion. Molecular genotyping with 13 distinct markers (antigenic genes and microsatellite loci) identified three to nine parasitemic recipients after transfusion with level of allelic identity suggesting 14% to 28% definite or possible transfusion-related parasitemia.
CONCLUSION: None of the currently available screening assays appear suitable to minimize transfusion malaria without compromising the blood supply in endemic areas.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23113534     DOI: 10.1111/j.1537-2995.2012.03943.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  13 in total

Review 1.  Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries.

Authors:  Victor J Drew; Lassina Barro; Jerard Seghatchian; Thierry Burnouf
Journal:  Blood Transfus       Date:  2017-04-13       Impact factor: 3.443

Review 2.  Plasmodium knowlesi - an emerging pathogen.

Authors:  M A Ahmed; J Cox-Singh
Journal:  ISBT Sci Ser       Date:  2015-04-13

3.  Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage.

Authors:  Shirley Owusu-Ofori; Joseph Kusi; Alex Owusu-Ofori; Graham Freimanis; Christine Olver; Caitlyn R Martinez; Shilo Wilkinson; Janna M Mundt; Shawn D Keil; Raymond P Goodrich; Jean-Pierre Allain
Journal:  Shock       Date:  2015-08       Impact factor: 3.454

4.  Transfusion-transmitted malaria: donor prevalence of parasitaemia and a survey of healthcare workers knowledge and practices in a district hospital in Ghana.

Authors:  Alex Owusu-Ofori; Dominic Gadzo; Imelda Bates
Journal:  Malar J       Date:  2016-04-23       Impact factor: 2.979

5.  Transfusion-transmitted severe Plasmodium knowlesi malaria in a splenectomized patient with beta-thalassaemia major in Sabah, Malaysia: a case report.

Authors:  Elspeth M Bird; Uma Parameswaran; Timothy William; Tien Meng Khoo; Matthew J Grigg; Ammar Aziz; Jutta Marfurt; Tsin W Yeo; Sarah Auburn; Nicholas M Anstey; Bridget E Barber
Journal:  Malar J       Date:  2016-07-12       Impact factor: 2.979

6.  Hepatitis B virus infection does not significantly influence Plasmodium parasite density in asymptomatic infections in Ghanaian transfusion recipients.

Authors:  Graham Lee Freimanis; Shirley Owusu-Ofori; Jean-Pierre Allain
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

Review 7.  What is the best strategy for the prevention of transfusion-transmitted malaria in sub-Saharan African countries where malaria is endemic?

Authors:  Jobert Richie N Nansseu; Jean Jacques N Noubiap; Shalom Tchokfe Ndoula; Albert Frank M Zeh; Chavely Gwladys Monamele
Journal:  Malar J       Date:  2013-12-28       Impact factor: 2.979

8.  Strategy to improve malaria surveillance system preventing transfusion-transmitted malaria in blood banks using molecular diagnostic.

Authors:  Sérgio Antônio Batista-Dos-Santos; Daniel Roberto C Freitas; Milene Raiol; Gleyce F Cabral; Ana Cecília Feio; Marinete M Póvoa; Maristela G Cunha; Ândrea Ribeiro-Dos-Santos
Journal:  Malar J       Date:  2018-10-01       Impact factor: 2.979

9.  The Incidence of Malaria Parasites in Screened Donor Blood for Transfusion.

Authors:  Samuel Antwi-Baffour; Ransford Kyeremeh; Atta Poku Amoako; Lawrence Annison; John Ocquaye-Mensah Tetteh; Mahmood Abdulai Seidu
Journal:  Malar Res Treat       Date:  2019-11-25

10.  Comparison of Commercial ELISA Kits to Confirm the Absence of Transmission in Malaria Elimination Settings.

Authors:  Lotus L van den Hoogen; Paolo Bareng; Joana Alves; Ralph Reyes; Malou Macalinao; Júlio M Rodrigues; José M Fernandes; Lara F Goméz; Tom Hall; Susheel K Singh; Kimberly Fornace; Jennifer Luchavez; Alan Kitchen; Peter Chiodini; Fe Espino; Kevin K A Tetteh; Gillian Stresman; Nuno Sepúlveda; Chris Drakeley
Journal:  Front Public Health       Date:  2020-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.